muscarinic acetylcholine M4 receptor positive allosteric modulators (Suven Life Sciences)

N/A

Report date: 2025/01/26 16:02:45
NME

Base Information

Drug Namemuscarinic acetylcholine M4 receptor positive allosteric modulators (Suven Life Sciences)
Drug Alias NameSUVN-L1305022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M4 modulators
TargetsMuscarinic acetylcholine receptor M4
Therapy Area/IndicationsSchizophreniaPsychotic DisordersAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuven Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaPsychotic DisordersAlzheimer Disease
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A